Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Anne Katrine Pagsberg; Pia Jeppesen; Dea Gowers Klauber; Karsten Gjessing Jensen; Ditte Ruda; Marie Stentebjerg-Olesen; Peter Jantzen; Simone Rasmussen; Eva Ann-Sofie Saldeen; Maj-Britt Glenn Lauritsen; Niels Bilenberg; Anne Dorte Stenstrom; Louise Nyvang; Sarah Madsen; Thomas M. Werge; Theis Lange; Christian Gluud; Maria Skoog; Per Winkel; Jens Richardt M. Jepsen; Birgitte Fagerlund; Christoph U Correll; Anders Fink-Jensen

doi:10.1016/S2215-0366(17)30166-9

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Anne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, Karsten Gjessing Jensen, Ditte Ruda, Marie Stentebjerg-Olesen, Peter Jantzen, Simone Rasmussen, Eva Ann-Sofie Saldeen, Maj-Britt Glenn Lauritsen, Niels Bilenberg, Anne Dorte Stenstrom, Louise Nyvang, Sarah Madsen, Thomas M. Werge, Theis Lange, Christian Gluud, Maria Skoog, Per Winkel, Jens Richardt M. JepsenBirgitte Fagerlund, Christoph U Correll, Anders Fink-Jensen

24 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The Lancet Psychiatry
Vol/bind	4
Udgave nummer	8
Sider (fra-til)	605-618
ISSN	2215-0366
DOI	https://doi.org/10.1016/S2215-0366(17)30166-9
Status	Udgivet - aug. 2017

Adgang til dokumentet

10.1016/S2215-0366(17)30166-9

Citationsformater

Pagsberg, A. K., Jeppesen, P., Klauber, D. G., Jensen, K. G., Ruda, D., Stentebjerg-Olesen, M., Jantzen, P., Rasmussen, S., Saldeen, E. A.-S., Lauritsen, M.-B. G., Bilenberg, N., Stenstrom, A. D., Nyvang, L., Madsen, S., Werge, T. M., Lange, T., Gluud, C., Skoog, M., Winkel, P., ... Fink-Jensen, A. (2017). Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. The Lancet Psychiatry, 4(8), 605-618. https://doi.org/10.1016/S2215-0366(17)30166-9

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. / Pagsberg, Anne Katrine ; Jeppesen, Pia; Klauber, Dea Gowers et al.
I: The Lancet Psychiatry, Bind 4, Nr. 8, 08.2017, s. 605-618.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Pagsberg, AK , Jeppesen, P, Klauber, DG, Jensen, KG, Ruda, D, Stentebjerg-Olesen, M, Jantzen, P, Rasmussen, S, Saldeen, EA-S, Lauritsen, M-BG, Bilenberg, N, Stenstrom, AD, Nyvang, L, Madsen, S, Werge, TM , Lange, T, Gluud, C, Skoog, M, Winkel, P, Jepsen, JRM, Fagerlund, B, Correll, CU & Fink-Jensen, A 2017, 'Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial', The Lancet Psychiatry, bind 4, nr. 8, s. 605-618. https://doi.org/10.1016/S2215-0366(17)30166-9

Pagsberg AK , Jeppesen P, Klauber DG, Jensen KG, Ruda D, Stentebjerg-Olesen M et al. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. The Lancet Psychiatry. 2017 aug.;4(8):605-618. doi: 10.1016/S2215-0366(17)30166-9

@article{97f2529684d9478987e334d34c29f443,

title = "Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial",

author = "Pagsberg, {Anne Katrine} and Pia Jeppesen and Klauber, {Dea Gowers} and Jensen, {Karsten Gjessing} and Ditte Ruda and Marie Stentebjerg-Olesen and Peter Jantzen and Simone Rasmussen and Saldeen, {Eva Ann-Sofie} and Lauritsen, {Maj-Britt Glenn} and Niels Bilenberg and Stenstrom, {Anne Dorte} and Louise Nyvang and Sarah Madsen and Werge, {Thomas M.} and Theis Lange and Christian Gluud and Maria Skoog and Per Winkel and Jepsen, {Jens Richardt M.} and Birgitte Fagerlund and Correll, {Christoph U} and Anders Fink-Jensen",

year = "2017",

month = aug,

doi = "10.1016/S2215-0366(17)30166-9",

language = "English",

volume = "4",

pages = "605--618",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "TheLancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

AU - Pagsberg, Anne Katrine

AU - Jeppesen, Pia

AU - Klauber, Dea Gowers

AU - Jensen, Karsten Gjessing

AU - Ruda, Ditte

AU - Stentebjerg-Olesen, Marie

AU - Jantzen, Peter

AU - Rasmussen, Simone

AU - Saldeen, Eva Ann-Sofie

AU - Lauritsen, Maj-Britt Glenn

AU - Bilenberg, Niels

AU - Stenstrom, Anne Dorte

AU - Nyvang, Louise

AU - Madsen, Sarah

AU - Werge, Thomas M.

AU - Lange, Theis

AU - Gluud, Christian

AU - Skoog, Maria

AU - Winkel, Per

AU - Jepsen, Jens Richardt M.

AU - Fagerlund, Birgitte

AU - Correll, Christoph U

AU - Fink-Jensen, Anders

PY - 2017/8

Y1 - 2017/8

U2 - 10.1016/S2215-0366(17)30166-9

DO - 10.1016/S2215-0366(17)30166-9

M3 - Journal article

SN - 2215-0366

VL - 4

SP - 605

EP - 618

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 8

ER -

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Adgang til dokumentet

Fingeraftryk

Citationsformater